Back to PharmaIndex

BEOVU

brolucizumab-dbll

Drug details

API

brolucizumab-dbll

Drug classification

Dosage form

INJECTABLE; INTRAVITREAL

API strength per dosage

6MG/0.05ML

Dose

Mechanism of action

Indications

Side effects

Pregnancy category

Precautions

Contraindications

PharmaProLearn

Excel Beyond Limits